Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MUNI-SEP TRIAL-The Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality; A Randomized Clinical Trial in Pakistan.

NCT05895240 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.

NCT NCT05895240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MUNI-SEP TRIAL-The Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality; A Randomized Clinical Trial in Pakistan.
Lead sponsor
Jinnah Postgraduate Medical Centre
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2023
Completion date
October 31, 2023
Enrollment
175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mods, septic shock, severe sepsis